Liver disease
- The endocannabinoid system and liver diseases (PubMed)
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (PubMed)
- Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis (PubMed)
- Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (PubMed)
- Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol (PubMed)
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice (PubMed)
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation (PubMed)
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (ScienceDirect)
- Endocannabinoids in Liver Disease (National Institute of Health)
- Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (PLOS)